Long-term and high-dose piracetam treatment of Alzheimer's disease. – Cost Effective Supplements

Long-term and high-dose piracetam treatment of Alzheimer's disease.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/8437693

Conclusion of this study

Thirty subjects completed the 1-year study. No improvement occurred in either group, but our results support the hypothesis that long-term administration of high doses of piracetam might slow the progression of cognitive deterioration in patients with AD. The most significant differences concerned the recall of pictures series and recent incident and remote memory. The drug was well-tolerated.